Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Phytochemical activity on NRF2 transcriptional activation WP3	4/15	4.230841235854126E-4	0.19969570633231473	0	0	10.666666666666666	82.85802159964132	NQO1;AIMP2;SLC7A11;GCLM
NRF2-ARE regulation WP4357	4/23	0.0023425796244436227	0.5528487913686949	0	0	6.956521739130435	42.13219167446808	NQO1;AIMP2;SLC7A11;GCLM
Human Complement System WP2806	8/97	0.002984595079747217	0.46957629254689554	0	0	3.2989690721649483	19.181166822317746	PRNP;LAMA5;CR1;C1QBP;WAS;SPP1;CD59;PRKACA
Dopamine metabolism WP2436	3/13	0.003684485563252584	0.4347692964638049	0	0	9.23076923076923	51.72576337848703	NQO1;PPP2CB;PRKACA
MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301	3/13	0.003684485563252584	0.3478154371710439	0	0	9.23076923076923	51.72576337848703	ITGAV;PLCG1;MAPK3
Osteopontin Signaling WP1434	3/13	0.003684485563252584	0.2898461976425366	0	0	9.23076923076923	51.72576337848703	SPP1;ITGAV;MAPK3
Myometrial Relaxation and Contraction Pathways WP289	10/156	0.005950114500251026	0.4012077205883549	0	0	2.564102564102564	13.139345681718174	CREB3;GNG4;PKIA;ADCY3;ARRB1;PLCG1;PRKACA;DGKZ;SLC8A1;YWHAG
Osteoclast Signaling WP12	3/16	0.006823799195615574	0.40260415254131887	0	0	7.5	37.40504171568808	AIMP2;GPR68;SPP1
Chemokine signaling pathway WP3929	10/164	0.008359541630999804	0.4384115166479898	0	0	2.4390243902439024	11.669150444430382	NCF1;CCL7;GNG4;WAS;ADCY3;ARRB1;CXCR6;RASGRP2;PLCB2;MAPK3
Benzene metabolism WP3891	2/6	0.0087524127649488	0.41311388250558334	0	0	13.333333333333332	63.17901162743442	NQO1;EPHX1
Primary Focal Segmental Glomerulosclerosis FSGS WP2572	6/72	0.00920869205168462	0.3951366043995582	0	0	3.333333333333333	15.625358175773448	LAMA5;CR1;PCNA;CTSL;ITGAV;PLCG1
Estrogen metabolism WP697	3/18	0.009582224106397506	0.37690081485163524	0	0	6.666666666666666	30.985637016835305	SULT1A1;NQO1;CYP1B1
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM WP3959	5/55	0.011932232343427853	0.43323182046907277	0	0	3.6363636363636362	16.103679782632323	PCNA;ACTL6A;RNF8;BAK1;TP53BP1
Benzo(a)pyrene metabolism WP696	2/9	0.019987498286726836	0.6738642279525048	0	0	8.888888888888888	34.779095880349324	EPHX1;CYP1B1
Tgif disruption of Shh signaling WP3674	2/9	0.019987498286726836	0.6289399460890045	0	0	8.888888888888888	34.779095880349324	TGIF1;TGIF2
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612	3/24	0.021284306818544364	0.6278870511470587	0	0	5.0	19.248926234484543	NQO1;EPHX1;GCLM
Signal Transduction of S1P Receptor WP26	3/25	0.02374801151107834	0.6593565548958221	0	0	4.8	17.95323109370892	S1PR1;PLCB2;MAPK3
Trans-sulfuration pathway WP2333	2/10	0.02457569018526242	0.6444292093024369	0	0	8.0	29.64798022792225	GCLM;CSAD
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	5/74	0.037751290429200716	0.9378215306622494	0	0	2.7027027027027026	8.856042217071249	LMNA;CACNA2D3;ITGB8;ITGAV;SLC8A1
Tumor suppressor activity of SMARCB1 WP4204	3/31	0.04160691113161275	0.981923102706061	0	0	3.8709677419354835	12.307699325969082	GLI4;SMARCD3;ACTL6A
Genes related to primary cilium development (based on CRISPR) WP4536	6/103	0.0445794522848911	1.0	0	0	2.3300970873786406	7.2477256012827525	MKKS;IFT43;ARL13B;CEP19;TULP3;IFT46
TGF-beta Receptor Signaling WP560	4/54	0.04578984055205085	0.9824002154803636	0	0	2.962962962962963	9.136868250298553	TGIF1;SPP1;SKIL;MAPK3
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969	2/14	0.04654140207685347	0.9551105121858626	0	0	5.7142857142857135	17.52807425877975	CDH1;TULP3
Resistin as a regulator of inflammation WP4481	3/33	0.048705626415457094	0.9578773195039895	0	0	3.6363636363636362	10.988948085170936	PLCG1;PLCB2;MAPK3
GPR40 Pathway WP3958	2/15	0.05283270093282616	0.9974813936117579	0	0	5.333333333333333	15.683333035361262	PLCG1;PLCB2
Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291	2/16	0.05940541077305161	1.0	0	0	5.0	14.116849831533036	SYTL1;UNC13D
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859	2/18	0.07332402120449992	1.0	0	0	4.444444444444444	11.612742279715478	CDH1;MAPK3
Endochondral Ossification WP474	4/64	0.07604536088191723	1.0	0	0	2.5	6.441063157581755	THRA;FGF18;SPP1;PRKACA
G1 to S cell cycle control WP45	4/64	0.07604536088191723	1.0	0	0	2.5	6.441063157581755	CREB3;CCNB1;PCNA;RPA3
Ferroptosis WP4313	3/40	0.07776165816733924	1.0	0	0	2.9999999999999996	7.6623203846665575	PRNP;SLC7A11;GCLM
Oxidative Damage WP3941	3/40	0.07776165816733924	1.0	0	0	2.9999999999999996	7.6623203846665575	PCNA;TRAF3;BAK1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	12/303	0.07950960377833823	1.0	0	0	1.584158415841584	4.010894989900366	PPP2CB;CREB3;LAMA5;CSF3R;GNG4;FGF18;SPP1;ITGB8;ITGAV;PELO;MET;MAPK3
Calcium Regulation in the Cardiac Cell WP536	7/149	0.0806876891210328	1.0	0	0	1.8791946308724832	4.730250970618586	GNG4;PKIA;ADCY3;ARRB1;PRKACA;SLC8A1;YWHAG
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036	3/42	0.08718222910547488	1.0	0	0	2.8571428571428568	6.970727895708977	TRAF3;TNFSF12;MAPK3
MAPK Signaling Pathway WP382	10/246	0.09066059734258862	1.0	0	0	1.6260162601626016	3.903467389706168	MAP4K2;DUSP10;LRRK2;FGF18;CACNA2D3;ARRB1;PRKACA;RASGRP2;MAPK8IP3;MAPK3
Tamoxifen metabolism WP691	2/21	0.09588684119947874	1.0	0	0	3.8095238095238093	8.931758172484527	SULT1A1;CYP1B1
Aryl Hydrocarbon Receptor Pathway WP2873	3/46	0.10736313441562158	1.0	0	0	2.6086956521739126	5.821404549935052	NQO1;SERPINB2;CYP1B1
Wnt Signaling Pathway and Pluripotency WP399	5/102	0.11254203614215841	1.0	0	0	1.9607843137254901	4.283193083396457	WNT10B;PPP2CB;MMP7;LRRK2;PPARD
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534	3/47	0.11266904115423244	1.0	0	0	2.553191489361702	5.57438450312141	MAP4K2;CDH1;ITGB8
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	FMO5
Sulindac Metabolic Pathway WP2542	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CYP1B1
Synthesis and Degradation of Ketone Bodies WP311	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	HMGCL
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	MAPK3
Vitamin B6-dependent and responsive disorders WP4228	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	PIGV
Prolactin Signaling Pathway WP2037	4/76	0.12252803470737	1.0	0	0	2.1052631578947367	4.419821937740146	AGAP2;NEK3;YWHAG;MAPK3
Ectoderm Differentiation WP2858	6/138	0.13258979837071028	1.0	0	0	1.7391304347826086	3.5139045905290915	SGSM3;NARS2;GAS2L1;SKIL;WDR44;PPARD
Thermogenesis WP4321	5/108	0.1340886770047024	1.0	0	0	1.8518518518518516	3.720840609651409	CREB3;SMARCD3;ACTL6A;ADCY3;PRKACA
One carbon metabolism and related pathways WP3940	3/52	0.14059914501552925	1.0	0	0	2.3076923076923075	4.527328570603137	CSAD;BCAT1;GCLM
Arylamine metabolism WP694	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	SULT1A1
SCFA and skeletal muscle substrate metabolism WP4030	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	PPARD
Follicle Stimulating Hormone (FSH) signaling pathway WP2035	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	PRKACA;MAPK3
Intraflagellar transport proteins binding to dynein WP4532	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	IFT43;IFT46
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018	3/55	0.15835797713897543	1.0	0	0	2.1818181818181817	4.020866466848246	TRAF3;PLCG1;MAPK3
NRF2 pathway WP2884	6/146	0.15970392874491499	1.0	0	0	1.643835616438356	3.015507325942322	NQO1;TXNRD1;SLC7A11;GCLM;SLC5A3;PPARD
Aflatoxin B1 metabolism WP699	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	EPHX1
Disorders of the Krebs cycle WP4236	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	SUCLA2
Cannabinoid receptor signaling WP3869	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	PRKACA;MAPK3
PDGFR-beta pathway WP3972	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	PLCG1;MAPK3
Matrix Metalloproteinases WP129	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	MMP11;MMP7
One Carbon Metabolism WP241	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	AMT;GART
Retinoblastoma Gene in Cancer WP2446	4/87	0.17333099873778088	1.0	0	0	1.839080459770115	3.223084551698343	CCNB1;RABIF;PCNA;RPA3
IL17 signaling pathway WP2112	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	TRAF3;MAPK3
Trans-sulfuration and one carbon metabolism WP2525	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	AMT;GCLM
Hippo-Merlin Signaling Dysregulation WP4541	5/120	0.18206485655756022	1.0	0	0	1.6666666666666665	2.838987167787887	CDH1;ITGB8;ITGAV;PRKACA;MET
Kit receptor signaling pathway WP304	3/59	0.18301812654553012	1.0	0	0	2.0338983050847457	3.453905245189201	BTK;PLCG1;MAPK3
MET in type 1 papillary renal cell carcinoma WP4205	3/59	0.18301812654553012	1.0	0	0	2.0338983050847457	3.453905245189201	PLCG1;MET;MAPK3
T-Cell antigen Receptor (TCR)  Signaling Pathway WP69	4/90	0.18828953531711135	1.0	0	0	1.7777777777777777	2.968487856688808	CD4;WAS;PLCG1;MAPK3
Amino Acid metabolism WP3925	4/91	0.193365469000841	1.0	0	0	1.7582417582417582	2.889095839916935	HMGCL;ARG2;BCAT1;GCLM
Apoptosis Modulation and Signaling WP1772	4/91	0.193365469000841	1.0	0	0	1.7582417582417582	2.889095839916935	TRAF3;PTRH2;BAK1;MAPK3
Alpha 6 Beta 4 signaling pathway WP244	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	LAMA5;MAPK3
Oxidative Stress WP408	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	NQO1;TXNRD1
Prion disease pathway WP3995	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	PRNP;MAPK3
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863	3/62	0.20213542656566247	1.0	0	0	1.9354838709677418	3.0944852471126474	CD4;PLCG1;MAPK3
DNA Mismatch Repair WP531	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	PCNA
Degradation pathway of sphingolipids, including diseases WP4153	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	GLA
Heme Biosynthesis WP561	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CPOX
BDNF-TrkB Signaling WP3676	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	HOMER1;PLCG1
Signaling of Hepatocyte Growth Factor Receptor WP313	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	MET;MAPK3
Endometrial cancer WP4155	3/63	0.20860938631238252	1.0	0	0	1.9047619047619047	2.985317601379297	CDH1;BAK1;MAPK3
Mammary gland development pathway - Involution (Stage 4 of 4) WP2815	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	CDH1
AGE/RAGE pathway WP2324	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	MMP7;NCF1;MAPK3
Non-small cell lung cancer WP4255	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	PLCG1;BAK1;MAPK3
Pathways Regulating Hippo Signaling WP4540	4/98	0.2299929805556841	1.0	0	0	1.6326530612244896	2.3995207997514747	CDH1;PRKACA;MET;PLCB2
PI3K-Akt Signaling Pathway WP4172	11/340	0.2330621315282591	1.0	0	0	1.2941176470588236	1.8848179085275811	PPP2CB;CREB3;LAMA5;CSF3R;GNG4;FGF18;SPP1;ITGB8;ITGAV;MET;MAPK3
Melatonin metabolism and effects WP3298	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	SULT1A1;CYP1B1
Photodynamic therapy-induced HIF-1 survival signaling WP3614	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	SLC16A1;BAK1
Methionine metabolism leading to Sulphur Amino Acids and related disorders WP4292	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	CSAD
Serotonin Transporter Activity WP1455	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	PPP2CB
Nuclear Receptors WP170	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	THRA;PPARD
PDGF Pathway WP2526	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	PLCG1;MAPK3
Bile Acids synthesis and enterohepatic circulation  WP4389	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	MAPK3
ATM Signaling Pathway WP2516	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	CCNB1;TP53BP1
Glycogen Synthesis and Degradation WP500	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	HK3;PPP2CB
IL-5 Signaling Pathway WP127	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	BTK;MAPK3
Regulation of toll-like receptor signaling pathway WP1449	5/139	0.26820709009249616	1.0	0	0	1.4388489208633093	1.8935192412132424	TRAF3;BTK;SPP1;CTNNAL1;MAPK3
Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	ACAP1;CARD9
Nuclear Receptors Meta-Pathway WP2882	10/319	0.27759539695436586	1.0	0	0	1.2539184952978055	1.6070101969447714	SULT1A1;FGD4;NQO1;SERPINB2;TXNRD1;CYP1B1;SLC7A11;GCLM;SLC5A3;PPARD
Disorders of Folate Metabolism and Transport WP4259	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	GART
Estrogen Receptor Pathway WP2881	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CYP1B1
Genes targeted by miRNAs in adipocytes WP1992	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	KCNQ1
Purine metabolism WP4224	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	ADA
Common Pathways Underlying Drug Addiction WP2636	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	PRKACA;MAPK3
DNA Replication WP466	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	PCNA;RPA3
Metabolic reprogramming in colon cancer WP4290	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	HK3;GART
Vitamin A and Carotenoid Metabolism WP716	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	SULT1A1;RDH10
Ciliary landscape WP4352	7/216	0.2965933573955227	1.0	0	0	1.296296296296296	1.5755097625082097	IFT43;ZMYND19;MFAP1;ERF;CDH23;IFT46;GLA
Cysteine and methionine catabolism WP4504	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	CSAD
Osteoblast Signaling WP322	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	ITGAV
Hedgehog Signaling Pathway WP4249	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	ARRB1;PRKACA
ATM Signaling Network in Development and Disease  WP3878	2/45	0.31071849114810757	1.0	0	0	1.7777777777777777	2.077987466447498	RNF8;TP53BP1
Ras Signaling WP4223	6/184	0.3130055721290346	1.0	0	0	1.3043478260869563	1.5150447212233813	GNG4;PLCG1;PRKACA;RASGRP2;MET;MAPK3
GPCRs, Class C Metabotropic glutamate, pheromone WP501	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	GPRC5A
Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CDH1
Aryl Hydrocarbon Receptor WP2586	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	NQO1;CYP1B1
Selenium Metabolism and Selenoproteins WP28	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	SARS2;TXNRD1
DNA IR-damage and cellular response via ATR WP4016	3/80	0.32329416211256273	1.0	0	0	1.4999999999999998	1.6937889773959778	PCNA;TDP1;TP53BP1
Integrated Breast Cancer Pathway WP1984	5/151	0.32654504468417483	1.0	0	0	1.3245033112582782	1.4823673874202945	CDH1;PKIA;BAK1;TFPI;RPP38
Energy Metabolism WP1541	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	PPARGC1B;PPARD
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	BTK;MAPK3
ID signaling pathway WP53	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ID3
Signaling Pathways in Glioblastoma WP2261	3/82	0.33702536869684624	1.0	0	0	1.4634146341463412	1.5916054733134235	PLCG1;MET;MAPK3
Spinal Cord Injury WP2431	4/118	0.34136073989964455	1.0	0	0	1.3559322033898304	1.4573769119991022	EFNB2;AIF1;FCGR2C;MAPK3
Breast cancer pathway WP4262	5/154	0.3413672638524862	1.0	0	0	1.2987012987012985	1.3958394300953163	WNT10B;CSNK2A2;FGF18;BAK1;MAPK3
Alzheimers Disease WP2059	3/83	0.34388610305783524	1.0	0	0	1.4457831325301203	1.5432936465472034	LRP1;PLCB2;MAPK3
IL-3 Signaling Pathway WP286	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	PRKACA;MAPK3
IL-9 Signaling Pathway WP22	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	MAPK3
Leptin Insulin Overlap WP3935	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	DGKZ
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	LRP1
Sulfation Biotransformation Reaction WP692	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	SULT1A1
Viral Acute Myocarditis WP4298	3/84	0.35074081138659435	1.0	0	0	1.4285714285714284	1.4967253676962142	CD4;AIF1;MAPK3
Synaptic signaling pathways associated with autism spectrum disorder WP4539	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	HOMER1;MAPK3
Pyrimidine metabolism WP4022	3/85	0.3575874776802259	1.0	0	0	1.4117647058823528	1.4518238879557512	POLR2J3;POLR3C;POLR2D
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	5/158	0.3611997205992443	1.0	0	0	1.2658227848101267	1.2890180138916039	VIPR1;KCNQ1;PRKACA;PPARGC1B;YWHAG
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	MAPK3
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	MAPK3
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	NQO1
TCA Cycle (aka Krebs or citric acid cycle) WP78	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	SUCLA2
Transcription co-factors SKI and SKIL protein partners WP4533	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	SKIL
Copper homeostasis WP3286	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	PRNP;STEAP4
Focal Adhesion WP306	6/198	0.37507643291277004	1.0	0	0	1.2121212121212122	1.1886369123390361	LAMA5;SPP1;ITGB8;ITGAV;MET;MAPK3
Extracellular vesicles in the crosstalk of cardiac cells WP4300	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	SPP1
Mitochondrial Gene Expression WP391	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	PPARGC1B
Serotonin Receptor 4/6/7 and NR3C Signaling WP734	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	MAPK3
Small Ligand GPCRs WP247	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	S1PR1
BMP Signaling Pathway in Eyelid Development WP3927	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	MAPK3
Nanomaterial induced apoptosis WP2507	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	BAK1
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	MAPK3
Urea cycle and metabolism of amino groups WP497	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	ARG2
IL-1 signaling pathway WP195	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	PLCG1;MAPK3
Pathogenic Escherichia coli infection WP2272	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	CDH1;WAS
Ebola Virus Pathway on Host WP4217	4/129	0.40381118360940044	1.0	0	0	1.2403100775193798	1.1247229489297248	CTSL;C1QBP;ITGAV;MAPK3
Adipogenesis WP236	4/130	0.4094511420274484	1.0	0	0	1.2307692307692308	1.0990002388867115	WNT10B;LMNA;ID3;PPARD
Mitochondrial complex I assembly model OXPHOS system WP4324	2/56	0.41009437639646396	1.0	0	0	1.4285714285714284	1.273382799199648	NDUFAF3;TMEM126B
Corticotropin-releasing hormone signaling pathway WP2355	3/93	0.41184736294433893	1.0	0	0	1.2903225806451613	1.1446483568607568	ARRB1;PLCG1;MAPK3
G Protein Signaling Pathways WP35	3/93	0.41184736294433893	1.0	0	0	1.2903225806451613	1.1446483568607568	GNG4;ADCY3;PRKACA
Neovascularisation processes WP4331	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	MAPK3
Nicotine Activity on Dopaminergic Neurons WP1602	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PRKACA
PI3K/AKT/mTOR - VitD3 Signalling WP4141	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	HK3
Regulation of Apoptosis by Parathyroid Hormone-related Protein WP3872	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	BAK1
Complement and Coagulation Cascades WP558	2/58	0.4274492922819714	1.0	0	0	1.379310344827586	1.1723029133595582	CR1;TFPI
Blood Clotting Cascade WP272	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	SERPINB2
Estrogen signaling pathway WP712	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	PRKACA
Glutathione metabolism WP100	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	GCLM
Hippo-Yap signaling pathway WP4537	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	MAP4K2
TYROBP Causal Network WP3945	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	CD4;SPP1
Angiogenesis WP1539	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	PLCG1
GPCRs, Class B Secretin-like WP334	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	VIPR1
miRNA regulation of p53 pathway in prostate cancer WP3982	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	PERP
Integrin-mediated Cell Adhesion WP185	3/101	0.4646041358021239	1.0	0	0	1.188118811881188	0.9107757110849387	CAPN5;ITGB8;ITGAV
Differentiation of white and brown adipocyte    WP2895	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PPARGC1B
Glycosylation and related congenital defects. WP4521	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	MGAT2
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	MAPK3
IL-7 Signaling Pathway WP205	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	MAPK3
Lung fibrosis WP3624	2/63	0.46961389196045544	1.0	0	0	1.2698412698412698	0.9598024487193709	SPP1;SKIL
Toll-like Receptor Signaling Pathway WP75	3/103	0.47747528768906305	1.0	0	0	1.1650485436893203	0.8612538337064508	TRAF3;SPP1;MAPK3
Vitamin D Receptor Pathway WP2877	5/182	0.47912961012621846	1.0	0	0	1.0989010989010988	0.8085539927011406	STEAP4;DUSP10;SPP1;SLC8A1;PPARD
Cytokines and Inflammatory Response WP530	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CD4
EPO Receptor Signaling WP581	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	MAPK3
Wnt/beta-catenin Signaling Pathway in Leukemia WP3658	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	PPARD
Metapathway biotransformation Phase I and II WP702	5/183	0.4839190063313735	1.0	0	0	1.0928961748633879	0.7932652771140319	SULT1A1;NAA30;EPHX1;CYP1B1;FMO5
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380	4/144	0.48684297836907303	1.0	0	0	1.111111111111111	0.7997929269299667	NCF1;SPP1;PLCG1;MAPK3
Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	ADCY3;MAPK3
Canonical  and Non-canonical Notch signaling WP3845	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	MFAP1
PPAR signaling pathway WP3942	2/67	0.5019777233846834	1.0	0	0	1.1940298507462686	0.8229248191077754	SLC27A2;PPARD
Mesodermal Commitment Pathway WP2857	4/147	0.5029167460190818	1.0	0	0	1.0884353741496597	0.748114979541874	ATP8B2;C1QBP;PRKACA;TRERF1
TLR4 Signaling and Tolerance WP3851	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	TRAF3
AMP-activated Protein Kinase (AMPK) Signaling WP1403	2/69	0.5176757123539347	1.0	0	0	1.1594202898550725	0.7633695892092621	CCNB1;PPARGC1B
Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982	2/69	0.5176757123539347	1.0	0	0	1.1594202898550725	0.7633695892092621	PRKACA;PPARGC1B
Gastric Cancer Network 1 WP2361	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	ACTL6A
Lipid Metabolism Pathway WP3965	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	PRKACA
MAPK Cascade WP422	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MAPK3
Selective expression of chemokine receptors during T-cell polarization WP4494	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	CD4
Statin Pathway WP430	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	LRP1
T-Cell Receptor and Co-stimulatory Signaling WP2583	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	PLCG1
miRs in Muscle Cell Differentiation WP2012	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	PRKACA
Extracellular vesicle-mediated signaling in recipient cells WP2870	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MET
Inflammatory Response Pathway WP453	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	LAMA5
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	PLCB2;MAPK3
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	EIF2B2
Toll-like Receptor Signaling WP3858	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	TRAF3
Chromosomal and microsatellite instability in colorectal cancer  WP4216	2/73	0.548068839980631	1.0	0	0	1.095890410958904	0.6590184981053064	BAK1;MAPK3
Wnt Signaling WP428	3/115	0.5513922772104151	1.0	0	0	1.0434782608695652	0.6211917769826543	WNT10B;CSNK2A2;PLCB2
Constitutive Androstane Receptor Pathway WP2875	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	SULT1A1
Development and heterogeneity of the ILC family WP3893	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	GFI1
Monoamine Transport WP727	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	PPP2CB
White fat cell differentiation WP4149	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	WNT10B
Nuclear Receptors in Lipid Metabolism and Toxicity WP299	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PPARD
Insulin Signaling WP481	4/160	0.5697792723914314	1.0	0	0	1.0	0.5625062345694026	MAP4K2;STXBP3;INPPL1;MAPK3
Leptin signaling pathway WP2034	2/76	0.5699678510175187	1.0	0	0	1.0526315789473684	0.5917634962819259	PLCG1;MAPK3
Cell Cycle WP179	3/120	0.5803125850880102	1.0	0	0	1.0	0.5441883808106572	CCNB1;PCNA;YWHAG
Wnt Signaling in Kidney Disease WP4150	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	WNT10B
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome WP4320	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	MTA2
miRNAs involvement in the immune response in sepsis WP4329	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	TRAF3
mRNA Processing WP411	3/126	0.6134239841513619	1.0	0	0	0.9523809523809523	0.4654275502112477	SNRNP40;U2AF2;CLASRP
Parkinsons Disease Pathway WP2371	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	LRRK2
Sleep regulation WP3591	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	ADA
Apoptosis WP254	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	TRAF3;BAK1
MicroRNAs in cardiomyocyte hypertrophy WP1544	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	PLCB2;MAPK3
G13 Signaling Pathway WP524	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	WAS
Bladder Cancer WP2828	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	CDH1
Microglia Pathogen Phagocytosis Pathway WP3937	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	NCF1
Selenium Micronutrient Network WP15	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	PRDX4;TXNRD1
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	WNT10B;CSNK2A2
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	3/132	0.6447354146223417	1.0	0	0	0.9090909090909091	0.399013869302999	MAP4K2;THRA;MAPK3
TGF-beta Signaling Pathway WP366	3/132	0.6447354146223417	1.0	0	0	0.9090909090909091	0.399013869302999	TGIF1;SKIL;MET
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation WP314	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	LMNA
IL-2 Signaling Pathway WP49	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	MAPK3
Allograft Rejection WP2328	2/89	0.6558581466108996	1.0	0	0	0.898876404494382	0.37915573334263386	LRRK2;CSNK2A2
Pancreatic adenocarcinoma pathway WP4263	2/89	0.6558581466108996	1.0	0	0	0.898876404494382	0.37915573334263386	BAK1;MAPK3
IL-6 signaling pathway WP364	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	MAPK3
ErbB Signaling Pathway WP673	2/91	0.6677839316144591	1.0	0	0	0.8791208791208791	0.3549807590642075	PLCG1;MAPK3
Interleukin-11 Signaling Pathway WP2332	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	MAPK3
TNF alpha Signaling Pathway WP231	2/92	0.6736206560152845	1.0	0	0	0.8695652173913043	0.3435549142768336	MAP4K2;MAPK3
Glycolysis and Gluconeogenesis WP534	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	HK3
Notch Signaling WP268	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	DTX3
Prostaglandin Synthesis and Regulation WP98	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	PPARGC1B
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	2/94	0.6850442087819228	1.0	0	0	0.8510638297872339	0.3219335356890655	WNT10B;CSNK2A2
Endoderm Differentiation WP2853	3/141	0.6882620673272747	1.0	0	0	0.8510638297872339	0.31794519299096285	ATP8B2;C1QBP;TRERF1
Regulation of Microtubule Cytoskeleton WP2038	1/46	0.688372038071095	1.0	0	0	0.8695652173913043	0.32471811668930733	PRKACA
Tryptophan metabolism WP465	1/46	0.688372038071095	1.0	0	0	0.8695652173913043	0.32471811668930733	CYP1B1
B Cell Receptor Signaling Pathway WP23	2/97	0.7015629289067601	1.0	0	0	0.8247422680412371	0.29232550701224613	BTK;PLCG1
Exercise-induced Circadian Regulation WP410	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	PPP2CB
Rett syndrome causing genes WP4312	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	EIF2B2
VEGFA-VEGFR2 Signaling Pathway WP3888	5/236	0.7062141444511628	1.0	0	0	0.847457627118644	0.2947769209567619	NCF1;ITGAV;PLCG1;SLC8A1;MAPK3
Hepatitis C and Hepatocellular Carcinoma WP3646	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	MAPK3
Structural Pathway of Interleukin 1 (IL-1) WP2637	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	MAPK3
Photodynamic therapy-induced AP-1 survival signaling. WP3611	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	BAK1
Regulation of Actin Cytoskeleton WP51	3/150	0.7276712445071681	1.0	0	0	0.7999999999999999	0.2543247359976752	FGF18;WAS;MAPK3
Translation Factors WP107	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	EIF2B2
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	NQO1
Phosphodiesterases in neuronal function WP4222	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	ADCY3
Senescence and Autophagy in Cancer WP615	2/105	0.7421134845024052	1.0	0	0	0.761904761904762	0.22724045976090407	SERPINB2;PCNA
Circadian rhythm related genes WP3594	4/201	0.7434367888046584	1.0	0	0	0.7960199004975124	0.2359972418836174	HOMER1;ID3;NR1D1;ADA
IL-4 Signaling Pathway WP395	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	MAPK3
Cardiac Hypertrophic Response WP2795	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	MAPK3
Hematopoietic Stem Cell Differentiation WP2849	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	CBFA2T3
Epithelial to mesenchymal transition in colorectal cancer WP4239	3/159	0.7630720538840987	1.0	0	0	0.7547169811320754	0.20407759787454713	WNT10B;CDH1;MAPK3
DNA Damage Response (only ATM dependent) WP710	2/110	0.7649933455424145	1.0	0	0	0.7272727272727272	0.1948277409678554	WNT10B;BAK1
Preimplantation Embryo WP3527	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	CDH1
EGF/EGFR Signaling Pathway WP437	3/162	0.7740120011092149	1.0	0	0	0.7407407407407407	0.18975400015077987	PCNA;INPPL1;PLCG1
RIG-I-like Receptor Signaling WP3865	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	TRAF3
Oxidation by Cytochrome P450 WP43	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	CYP1B1
ESC Pluripotency Pathways WP3931	2/116	0.7901054823546598	1.0	0	0	0.689655172413793	0.16247504859752454	WNT10B;FGF18
Oncostatin M Signaling Pathway WP2374	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	MAPK3
Pathways Affected in Adenoid Cystic Carcinoma WP3651	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	CMTR2
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	1/66	0.8124529129968876	1.0	0	0	0.6060606060606061	0.12587716344981695	PLCG1
Folate Metabolism WP176	1/66	0.8124529129968876	1.0	0	0	0.6060606060606061	0.12587716344981695	GART
Histone Modifications WP2369	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	KMT2D
DNA Damage Response WP707	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	CCNB1
RAC1/PAK1/p38/MMP2 Pathway WP3303	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	MAPK3
miRNA Regulation of DNA Damage Response WP1530	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	CCNB1
Peptide GPCRs WP24	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	CXCR6
Pathways in clear cell renal cell carcinoma WP4018	1/85	0.8842811683327172	1.0	0	0	0.47058823529411764	0.057873036795879476	HK3
Hair Follicle Development: Cytodifferentiation (Part 3 of 3) WP2840	1/87	0.8900189133928805	1.0	0	0	0.45977011494252873	0.05356899562230545	PERP
Androgen receptor signaling pathway WP138	1/90	0.8980975124258875	1.0	0	0	0.4444444444444444	0.047767390278977744	TGIF1
GPCRs, Other WP117	1/91	0.9006565431609593	1.0	0	0	0.43956043956043955	0.045991775475609106	S1PR1
Neural Crest Differentiation WP2064	1/101	0.9229711233572102	1.0	0	0	0.396039603960396	0.03174547746753108	CDH1
Nonalcoholic fatty liver disease WP4396	1/155	0.9805427289631335	1.0	0	0	0.25806451612903225	0.005070724012007306	BAK1
GPCRs, Class A Rhodopsin-like WP455	2/257	0.9890091905685515	1.0	0	0	0.311284046692607	0.003440203770698693	GPR68;NMUR1
